Correction to Unprecedented Thiacalixarene Fucoclusters as Strong

May 10, 2019 - Correction to Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/DC-SI...
0 downloads 0 Views 982KB Size
Correction Cite This: Bioconjugate Chem. XXXX, XXX, XXX−XXX

pubs.acs.org/bc

Correction to Unprecedented Thiacalixarene Fucoclusters as Strong Inhibitors of Ebola cis-Cell Infection and HCMV-gB Glycoprotein/ DC-SIGN C‑type Lectin Interaction Marwa Taouai, Vanessa Porkolab, Khouloud Chakroun, Coraline Cheneau, Joanna Luczkowiak, Rym Abidi, David Lesur, Peter J. Cragg, Franck Halary,□ Rafael Delgado, Franck Fieschi,* and Mohammed Benazza* Downloaded via 95.85.80.254 on May 15, 2019 at 10:43:48 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.

Bioconjugate Chem. 2019, 30, 1114−1126. DOI: 10.1021/acs.bioconjchem.9b00066 S Supporting Information *



We wish to make corrections to the following: Figure 1, Scheme 1, and the TOC graphic. There is also a corrected Supporting Information file. Corrected TOC graphic is below:

ASSOCIATED CONTENT

S Supporting Information *

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.bioconjchem.9b00300. Corrected SI (PDF)

Figure 1. New designed fucoclusters 1, 2, and 3 for inhibition of DC-SIGN dependent viral infections.

© XXXX American Chemical Society

A

DOI: 10.1021/acs.bioconjchem.9b00300 Bioconjugate Chem. XXXX, XXX, XXX−XXX

Correction

Bioconjugate Chemistry

Scheme 1. Convergent Strategy for Synthesis of Fucoclusters 1 and 2 Using Two Key Components, the Ugi Adduct 7 and the Tetraazido-Thiacalixarene 6a

a i. 1-Bromo-3-chloro-propane, K2CO3, refluxed acetone; ii. NaN3, DMF, 90 °C; iii. MeOH, rt, 24 h; iv. CuSO4·5H2O/Na-ascorbate, H2O/THF/ tBuOH, 60 °C, 3 h; or CuI/DIEA, CH3CN, MW, 30 min; v. MeONa, MeOH, rt; vi. NH2OHaq, KCNcat, MeOH/THF, rt.

B

DOI: 10.1021/acs.bioconjchem.9b00300 Bioconjugate Chem. XXXX, XXX, XXX−XXX